Morgan Stanley Sticks to Its Buy Rating for Cardinal Health (CAH)
Morgan Stanley analyst Erin Wright maintained a Buy rating on Cardinal Health (CAH – Research Report) today and set a price target of $136.00.
Hosted on MSN1d
Cardinal Health to Report Q2 Earnings: What's in Store for the Stock?
Cardinal Health, Inc. CAH is scheduled to report fiscal second-quarter 2025 results on Jan. 30, before the opening bell. In ...
Cardinal Health stock soars to all-time high of $130.1
Cardinal Health Inc (NYSE:CAH). shares have reached an unprecedented peak, with the stock hitting an all-time high of $130.1. The $31.2 billion healthcare provider has shown remarkable momentum, with ...